longcovid
Tausende Menschen wollen kommende Woche an einer internationalen Online-Konferenz zu Long Covid und Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom (ME/CFS) teilnehmen. Die Veranstaltung mit dem Namen #UniteToFight2024 findet am 15. und 16. Mai statt und wurde von fünf Betroffenen aus Deutschland organisiert. «Das Publikum wird Patienten, Betreuer, Forscher, Kliniker, Politiker und Journalisten umfassen», teilte Marco Wetzel, einer der Gründer, im Vorhinein mit. Bislang hätten sich fast 7000 Menschen für die kostenlose Veranstaltung angemeldet (Stand 8. Mai). Geplant sind zahlreiche ...
DPA (German)
A new study suggests that COVID-19 can impact cognitive function a year or more after people have contracted the virus. The study enrolled more than 140,000 participants and assessed the cognitive and memory abilities of individuals who had recovered from COVID-19 compared to those who had not been infected. Study participants were tasked with completing an online cognitive evaluation using a platform called Cognitron. The tasks were designed to identify nuanced changes to cognition such as memory, reasoning, attention, and impulsivity. “The potential long-term effects of COVID-19 on cognitive...
Euronews (English)
Mediziner haben eine körperliche Ursache für den sogenannten Gehirnnebel bei Long-Covid-Patienten gefunden. Demnach verursacht die Virusinfektion eine Störung des Blutversorgungssystems im Gehirn. Die Blutgefäße werden durchlässiger und können das Gehirn schlechter von Krankheitserregern, Giften und anderen Substanzen im Blut abschirmen, berichtet die Forschergruppe um Matthew Campbell vom Trinity College Dublin und Colin Doherty vom St James’s Hospital in Dublin (Irland) im Fachmagazin «Nature Neuroscience». «Zum ersten Mal konnten wir zeigen, dass undichte Blutgefäße im menschlichen Gehirn z...
DPA (German)
A COVID-19 antiviral drug has been underused in Europe with about 3.1 million courses of the medicine set to expire in the UK, Germany, Spain, Italy, and France by the end of this month. With clinical trial data showing a nearly 90 per cent reduction in the risk of severe illness, Paxlovid first came to market as a critical tool against COVID-19 at the beginning of 2022. But the UK-based global health data and analytics company Airfinity said in a report earlier this year that a few of the batches initially delivered by the drug’s manufacturer Pfizer already started expiring in July 2023, acco...
Euronews (English)
Paris (AFP) - One in three people who overcome Covid-19 suffer from a neurological or psychiatric diagnosis six months on, according to the largest study so far published on the mental toll that long-Covid takes on survivors. Authors said the research, printed Wednesday in The Lancet Psychiatry journal, proved that Covid-19 patients were significantly more likely to develop brain conditions than those suffering from other respiratory tract infections. Studying the health records of more than 230,000 patients who had recovered from Covid-19, they found that 34 percent were diagnosed with a neur...
AFP
Geneva (AFP) - It is time to start solving the mystery of Long Covid, an aspect of the pandemic blighting millions of lives, the World Health Organization's leader on post-Covid conditions told AFP. Little is known about why some people, after coming through the acute phase of Covid-19, struggle to recover and suffer ongoing symptoms including tiredness, brain fog, cardiac and neurological disorders. At this stage of the pandemic, the world is fixated on vaccine roll-out and new, more contagious variants of the coronavirus. However, Long Covid deserves similar urgent attention, said Janet Diaz...
AFP
Paris (AFP) - Snatching moments of clarity through the brain fog that was among the lingering symptoms of her coronavirus infection, Hannah Davis joined a team of similarly ill researchers and launched a study of what is now called "long Covid".The survey was initially "for ourselves, to understand what was happening with our own bodies", Davis said. But with so little data available, it was soon informing global policymakers.Davis is part of an international patient-led movement of people who, when they were struck down with unexplained, debilitating symptoms, developed social media networks,...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら